Prostate Cancer Information from TAP Pharmaceuticals
Healthcare Professional Website
Prostate Cancer Support from TAP
CANCERFACTS.COM
www.cancerfacts.com/Home_SupportGroups.asp

Cancerfacts.com provides a locator page to search for prostate cancer support groups by state.

MAN TO MAN
(800) ACS-2345
www.cancer.org/docroot/ESN/content/
ESN_3_1x_Man_to_Man_36.asp?sitearea=SHR

Sponsored by the American Cancer Society, Man to Man offers group education, discussion and support for men with prostate cancer. Volunteer coordinators invite speakers, publicize meeting schedules and make local arrangements for monthly meetings. To find out if these services are available in your area, contact your local ACS office or call (800) ACS-2345.

US TOO Prostate Cancer Education and Support
(800) 808-7866
www.ustoo.com

US TOO helps survivors of prostate cancer and prostate disease and their families lead healthy and productive lives. This organization offers fellowship, shared counseling, and discussion sessions in both formal and informal settings.
Prostate Cancer Treatment Information
Prostate Cancer Resources from TAP
Prostate Cancer Treatment Tools from TAP Keeping your appointments is important. Use our Appointment Reminder tools to help you stay on track with your therapy.
Prostate Cancer and Prostate Specific Antigen (PSA) Levels
PSA Tool Use our PSA Tracker to record and chart your PSA test results over time. This tool allows you to print a graph of your PSA levels to discuss with your doctor.

Important Safety and Other Information

Lupron Depot is indicated for the palliative treatment of advanced prostate cancer. The most common side effect associated with Lupron Depot is hot flashes. Like other treatment options, LH-RH agonists may cause impotence. Symptoms may worsen over the first few weeks of treatment. Periodic monitoring of PSA and serum testosterone levels is recommended. Lupron Depot–4 Month 30mg, –3 Month 22.5mg and 7.5mg dosage forms are not indicated for use in women. For further information about Lupron Depot, please see the complete prescribing information and the patient product information.

©2006 TAP Pharmaceutical Products Inc.